Status:
COMPLETED
Comorbidities and Risk Score in COVID-19 Patients
Lead Sponsor:
University of Milano Bicocca
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
Retrospective multi-center cohort study. Consecutive patients hospitalized for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) up to October 2020 will be included. Patients are followed u...
Detailed Description
Background A virus causing clusters of severe pneumonia was first detected in the city of Wuhan, China, in December 2019. This pathogen was designated as SARS-CoV-2. Although of probable zoonotic or...
Eligibility Criteria
Inclusion
- Inclusion criteria
- the presence of SARS-CoV-2 infection
- age \>18 years,
- diagnosis of SARS-CoV-2 infection up to October 2020
- Exclusion criteria
- • None
Exclusion
Key Trial Info
Start Date :
December 30 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 29 2021
Estimated Enrollment :
4555 Patients enrolled
Trial Details
Trial ID
NCT04670094
Start Date
December 30 2020
End Date
May 29 2021
Last Update
November 9 2022
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
ASST Grande Ospedale Metropolitano Niguarda
Milan, Italy
2
ASST Spedali Civili
Montichiari, Italy
3
ASST Monza-Ospedale San Gerardo
Monza, Italy
4
Humanitas Clinical and Research Hospital
Rozzano, Italy